Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Prelude Therapeutics Incorporated - Common Stock
(NQ:
PRLD
)
3.090
-0.140 (-4.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prelude Therapeutics Incorporated - Common Stock
< Previous
1
2
3
4
5
Next >
Prelude Therapeutics Announces Launch of Proposed Public Offering
May 17, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
May 08, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May
April 27, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Expert Ratings for Prelude Therapeutics
↗
November 21, 2022
Via
Benzinga
Analyst Ratings for Prelude Therapeutics
↗
November 21, 2022
Via
Benzinga
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
April 11, 2023
Eight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
The 7 Worst Stocks to Buy Now
↗
March 18, 2023
With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now.
Via
InvestorPlace
Prelude Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
March 15, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Prelude Therapeutics Announces Clinical Trial Collaboration with BeiGene to Evaluate PRT2527 in Combination with Zanubrutinib in Hematologic Cancers
March 15, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Prelude Therapeutics To Participate in Barclays Global Healthcare Conference
March 01, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Prelude Therapeutics To Participate in Two Upcoming Healthcare Investor Conferences
February 09, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Carvana, Crocs And Other Big Losers From Monday
↗
November 22, 2022
U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 03, 2023
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Via
Benzinga
Why This Prelude Therapeutics Analyst Disagrees With 2 Others And Downgraded The Stock
↗
November 21, 2022
Shares of Prelude Therapeutics Inc (NASDAQ: PRLD) came under pressure during early trading on Monday.
Via
Benzinga
Prelude Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Marten Transport, Silvergate Capital And Some Other Big Stocks Moving Lower On Tuesday
↗
October 18, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Prelude Therapeutics Receives FDA Clearance of IND for PRT3789, a Potent and Selective First-in-Class SMARCA2 Protein Degrader
October 18, 2022
Phase 1 Study Will Include Biomarker Selected Patients with Advanced Solid Tumors
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
↗
July 29, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
↗
September 09, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 24, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
April 21, 2022
On Thursday, 236 companies hit new 52-week lows.
Via
Benzinga
68 Biggest Movers From Yesterday
↗
March 16, 2022
Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
↗
March 15, 2022
Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
March 15, 2022
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022
↗
March 15, 2022
Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
February 28, 2022
Gainers IntriCon (NASDAQ:IIN) shares increased by 37.4% to $23.93 during Monday's regular session. The current volume of 1.0 million shares is 3684.0% of IntriCon'...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
March 01, 2022
During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the...
Via
Benzinga
67 Biggest Movers From Yesterday
↗
March 01, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2022
↗
February 28, 2022
Upgrades According to DA Davidson, the prior rating for Envestnet Inc (NYSE:ENV) was changed from Neutral to Buy. In the fourth quarter, Envestnet showed an EPS of $0.50, compared...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
